Phytopharmaceutical Approach in the Development of Red Ginger (Zingiber officinale var. rubrum) Ointment for Inflammation and Pain Management
JURNAL PEMBELAJARAN DAN BIOLOGI NUKLEUS · 16.11.2025 · 11 (3) · 1266-1279
DOI: 10.36987/jpbn.v11i3.8135 ↗Kurz gefasst
Fachartikel in der Zeitschrift JURNAL PEMBELAJARAN DAN BIOLOGI NUKLEUS, online erschienen am 16.11.2025. Verfasst von Raissa Fitri und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Themen: Schmerzmanagement
Abstract (Originalsprache)
Background
Red ginger (Zingiber officinale var. rubrum) is a variant of Z. officinale distinguished by its elevated levels of phenolic compounds—particularly gingerols, shogaols, and zingerone—that exhibit potent anti-inflammatory and analgesic effects. Topical formulations enable localized drug delivery, reducing systemic exposure and minimizing adverse effects commonly associated with oral nonsteroidal anti-inflammatory drugs (NSAIDs). Methodology: Dried red ginger rhizomes were powdered and extracted with 70% ethanol via maceration. The concentrated extract was incorporated into a white soft paraffin–lanolin base to produce ointments containing 5%, 10%, and 15% w/w extract. The formulations were assessed for physicochemical stability, including organoleptic characteristics, pH, spreadability, adhesion, and homogeneity. Anti-inflammatory activity was evaluated using the carrageenan-induced paw edema model in Wistar rats (n = 6 per group), with blank base and diclofenac sodium ointment (1% w/w) serving as negative and positive controls, respectively.
Findings
All ointments exhibited stable physicochemical properties within pharmacopeial acceptance limits (pH 5.2–5.9; spreadability 5.6–6.4 cm; adhesion >1 s). In vivo, red ginger ointments significantly reduced paw edema in a dose-dependent manner (p < 0.05). The 15% formulation achieved 60.8% inhibition (0.47 ± 0.05 mL at 5 h), comparable to diclofenac ointment (0.48 ± 0.06 mL; p = 0.71). Contribution: The study establishes that red ginger retains pharmacological activity when formulated into a topical base, confirming its potential as a stable, safe, and effective phytopharmaceutical for localized inflammation management. These findings support further preclinical and clinical studies toward its development as a natural alternative to synthetic topical NSAIDs
Zitieren
APA
Fitri, R., Ginting, G. A. B., Asdian, F., Siahaan, D. K., Nurfadilla, S., & Adiansyah, A. (2025). Phytopharmaceutical Approach in the Development of Red Ginger (Zingiber officinale var. rubrum) Ointment for Inflammation and Pain Management. JURNAL PEMBELAJARAN DAN BIOLOGI NUKLEUS, 11(3), 1266-1279. https://doi.org/10.36987/jpbn.v11i3.8135
Vancouver
Fitri R, Ginting GAB, Asdian F, Siahaan DK, Nurfadilla S, Adiansyah A. Phytopharmaceutical Approach in the Development of Red Ginger (Zingiber officinale var. rubrum) Ointment for Inflammation and Pain Management. JURNAL PEMBELAJARAN DAN BIOLOGI NUKLEUS. 2025;11(3):1266-1279. doi:10.36987/jpbn.v11i3.8135
BibTeX
@article{Fitri2025,
author = {Fitri, Raissa and Ginting, Grace Anastasia Br and Asdian, Fanny and Siahaan, Destina Karinia and Nurfadilla, Sulistia and Adiansyah, Adiansyah},
title = {Phytopharmaceutical Approach in the Development of Red Ginger (Zingiber officinale var. rubrum) Ointment for Inflammation and Pain Management},
journal = {JURNAL PEMBELAJARAN DAN BIOLOGI NUKLEUS},
year = {2025},
volume = {11},
number = {3},
pages = {1266--1279},
doi = {10.36987/jpbn.v11i3.8135}
}
EUVIMED